Search Results

You are looking at 31 - 40 of 133 items for :

  • "chronic hepatitis C" x
  • Refine by Access: All Content x
Clear All

1325 Arena, U., Vizzutti, F., Abraldes, J. G., et al.: Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut, 2008, 57 , 1288

Restricted access
Orvosi Hetilap
Authors: Zsuzsa Schaff, Alíz Gógl, Réka Dóra, and Tünde Halász

–44. 11 Jármay, K., Karácsony, G., Ozsvár, Z., et al.: Assessment of histological features in chronic hepatitis C. Hepatogastroenterology, 2002, 49 (43), 239

Open access

McHutchison, J. G., Manns, M., Patel, K. és mtsai: Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology, 2002, 123 , 1061

Restricted access

Bedossa, P., Dargere, D., Paradis, V.: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology, 2003, 38 , 1449–1457. Paradis V. Sampling variability of liver

Restricted access

mellitus: meta-analysis. World J Gastroenterol. 2012; 18: 1642–1651. 7 Dai CY, Yeh ML, Huang CF, et al. Chronic hepatitis C infection is associated with insulin resistance and lipid

Open access

patients with chronic hepatitis C after liver transplantation: a randomized study Gastroenterology 124 642 – 650 . [46]. G. Lengyel L. Kóbori I. Fehérvári 2003 Combined interferon-alfa-2b and ribavirin therapy in patients with

Restricted access
Orvosi Hetilap
Authors: Mihály Makara, Gábor Horváth, Judit Gervain, Alajos Pár, Ferenc Szalay, László Telegdy, István Tornai, Eszter Újhelyi, and Béla Hunyady

plus ribavirin in patients with chronic hepatitis C. Hepatology, 2003, 38 , 645–652. McHutchison J. G. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin

Open access

for initial treatment of chronic hepatitis C: a randomized trial. Lancet, 2001, 358 (9286), 958–965. 2 Hadziyannis, S. J., Sette, H. Jr., Morgan, T. R., et al

Restricted access
Orvosi Hetilap
Authors: Anita Netyő, Gabriella Lengyel, and János Fehér

. és mtsai: High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no evidence of HCV transmission among sexual partners. Infection, 1999, 27 , 86–91. Biasin M. R

Restricted access
Orvosi Hetilap
Authors: Béla Hunyady, Zsuzsanna Gerlei, Judit Gervain, Gábor Horváth, Gabriella Lengyel, Alajos Pár, László Rókusz, Ferenc Szalay, László †Telegdy, István Tornai, Klára Werling, and Mihály Makara

-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA, 2012, 308 (24), 2584–2593. Makara, M., Horváth, G., Szalay, F., et al.: Organizational characteristics of treatment for chronic

Open access